NKI-AVL
dr. Frederieke van Duijnhoven (NKI-AvL)
dr. John Maduro (UMCG)
prof. dr. Marie-Jeanne Vrancken Peeters (NKI-AvL)
dr. Jolien Tol (JBZ)
prof. dr. Liesbeth Boersma (MAASTRO clinic)
dr. Nicola Russell (NKI-AvL)
Dr. S.M. van den Berg (BOOG Study Center)
Josefien van Olmen (per 1-11-2024: Annemijn Beerthuizen)
arts onderzoeker NKI-AvL
descartes@nki.nl
T: 020-512 4144
NKI-AVL
NKI-AVL
IKNL
KWF, pink ribbon
Prospective single arm multicenter national study.
To show that omitting radiotherapy in patients with a pCR to NST results in an excellent 5 year local control rate.
The primary endpoint is the 5-year local recurrence rate. Secondary endpoints include local non-salvageable recurrence free survival, quality of life, cancer worry, regional recurrence, distant recurrence free survival, disease-specific survival and overall survival.
Node-negative patients with a pathologic complete response to neoadjuvant systemic therapy who were treated with breast conserving surgery.
